subject: UNII:5W7SK85BMU

object_name: pancreatic neoplasm


subject: UNII:5W7SK85BMU

subject_name: CABOTAMIG

object_name: exocrine pancreatic carcinoma

tested_intervention: unsure


subject: UNII:5W7SK85BMU

object_name: malignant pancreatic neoplasm


subject: UNII:5W7SK85BMU

object_name: esophageal adenocarcinoma


subject: UNII:5W7SK85BMU

object_name: colorectal adenocarcinoma


subject: UNII:5W7SK85BMU

object_name: cholangiocarcinoma


subject: UMLS:C5909010

subject_name: Cabotamig

object_name: digestive system cancer


subject: UMLS:C5909010

object_name: digestive system neuroendocrine tumor, grade 1/2


subject: UMLS:C5909010

object_name: Stomach cancer


subject: UMLS:C5909010

object_name: gastric cancer


subject: UMLS:C5909010

object_name: liver cancer


subject: UMLS:C5909010

object_name: liver neoplasm


subject: UMLS:C5909010

object_name: Adult Liver Carcinoma


subject: UMLS:C5909010

object_name: liver carcinoma


subject: UMLS:C5909010


subject: UMLS:C5909010


subject: UMLS:C5909010


subject: UMLS:C5909010


subject: UMLS:C5909010


subject: UMLS:C5909010


subject: UMLS:C5706464

subject_name: Anti-CDH17/Anti-CD3 Bispecific Antibody ARB202


subject: UMLS:C5706464


subject: UMLS:C5706464


subject: UMLS:C5706464


subject: UMLS:C5706464


subject: UMLS:C5706464


subject: UMLS:C5706464


subject: UMLS:C5706464


subject: UMLS:C5706464


subject: UMLS:C5706464


subject: UMLS:C5706464


subject: UMLS:C5706464


subject: UMLS:C5706464


subject: UMLS:C5706464


subject: UNII:8G388563M7

subject_name: Telotristat ethyl

object_name: Hepatic impairment

tested_intervention: yes


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: follicular lymphoma


subject: CHEBI:63791

object_name: marginal zone lymphoma


subject: CHEBI:63791

object_name: MALT lymphoma


subject: UNII:QQA9MLH692

subject_name: Tafasitamab


subject: UNII:QQA9MLH692


subject: UNII:QQA9MLH692


subject: UMLS:C2987409


subject: UMLS:C2987409


subject: UMLS:C2987409


subject: UMLS:C2348849

subject_name: ALVAC-MART-1 Vaccine

object_name: metastatic melanoma


subject: UMLS:C2348849

object_name: skin neoplasm


subject: UMLS:C2348849

object_name: skin cancer


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin


subject: UNII:M89N0Q7EQR


subject: UNII:M89N0Q7EQR


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: PUBCHEM.COMPOUND:66555030

subject_name: Oliceridine

object_name: Acute Pain


subject: CHEBI:135515

subject_name: Bendamustine

object_name: Carcinoma breast stage IV


subject: CHEBI:48775

object_name: leukemia


subject: CHEBI:48775

object_name: childhood leukemia


subject: CHEBI:48775

object_name: B-cell neoplasm


subject: CHEBI:48775

object_name: Childhood Large Cell Lymphoma


subject: CHEBI:48775

object_name: reticulosarcoma


subject: CHEBI:48775

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:48775

object_name: non-Hodgkin lymphoma


subject: CHEBI:48775

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:48775

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:48775

object_name: acute lymphoblastic leukemia


subject: CHEBI:48775

object_name: leukemia, acute lymphocytic, susceptibility to, 1


subject: CHEBI:8673

subject_name: Pyrimethamine


subject: CHEBI:8673


subject: CHEBI:8673


subject: CHEBI:8673


subject: CHEBI:8673


subject: CHEBI:8673


subject: CHEBI:8673


subject: CHEBI:8673


subject: CHEBI:8673


subject: CHEBI:8673


subject: CHEBI:8673


subject: CHEBI:22977

subject_name: Cadmium


subject: CHEBI:22977


subject: CHEBI:22977


subject: CHEBI:22977


subject: CHEBI:22977


subject: CHEBI:22977


subject: CHEBI:22977


subject: CHEBI:22977


subject: CHEBI:22977


subject: CHEBI:22977


subject: CHEBI:22977


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: esophageal varices


subject: PUBCHEM.COMPOUND:46783403

object_name: Gastrointestinal hemorrhage


subject: PUBCHEM.COMPOUND:46783403

object_name: Cirrhosis


subject: UMLS:C2366367

subject_name: Cinryze

object_name: kidney failure


subject: CHEBI:151315

subject_name: Heparin


subject: KEGG.COMPOUND:C00374


subject: CHEBI:23066

subject_name: cephalosporin

object_name: abscess


subject: CHEBI:23066

object_name: Cuffing (morphologic abnormality)


subject: CHEBI:23066

object_name: Consent Type - Hysterectomy


subject: CHEBI:23066

object_name: cellulitis


subject: CHEBI:23066

object_name: cellulitis on exam (physical finding)


subject: CHEBI:23066

object_name: VAGINOSIS


subject: CHEBI:23066

object_name: vaginal disease


subject: CHEMBL.COMPOUND:CHEMBL5482975

subject_name: CEPHALOSPORIN


subject: CHEMBL.COMPOUND:CHEMBL5482975


subject: CHEMBL.COMPOUND:CHEMBL5482975


subject: CHEMBL.COMPOUND:CHEMBL5482975


subject: CHEMBL.COMPOUND:CHEMBL5482975


subject: CHEMBL.COMPOUND:CHEMBL5482975


subject: CHEMBL.COMPOUND:CHEMBL5482975


subject: UMLS:C4706514

subject_name: Cephalosporin product


subject: UMLS:C4706514


subject: UMLS:C4706514


subject: UMLS:C4706514


subject: UMLS:C4706514


subject: UMLS:C4706514


subject: UMLS:C4706514


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Pneumonia caused by SARS-CoV-2


subject: CHEBI:41879

object_name: reported history of cataract surgery


subject: CHEBI:75922

subject_name: Nepafenac


subject: CHEBI:6121

subject_name: Ketamine

object_name: Post-Operative Pain


subject: CHEBI:6121

object_name: bariatric surgery candidate


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: Urinary Tract Infection, CTCAE


subject: UMLS:C1170167

subject_name: Cipro XR

object_name: urinary tract infection


subject: UMLS:C1170167

object_name: bacterial urinary tract infection


subject: UMLS:C1170167


subject: PUBCHEM.COMPOUND:382513

subject_name: Aclacinomycin X

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:382513

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:152864

subject_name: Aclacinomycin Y


subject: PUBCHEM.COMPOUND:152864


subject: DRUGBANK:DB19070

subject_name: Aklavine


subject: DRUGBANK:DB19070


subject: CHEBI:74619

subject_name: Aclarubicin


subject: CHEBI:74619


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: Childhood Breast Carcinoma


subject: UNII:M487QF2F4V

object_name: breast carcinoma


subject: UNII:M487QF2F4V

object_name: breast cancer


subject: UMLS:C1706792

subject_name: Amifostine Trihydrate


subject: UMLS:C1706792


subject: UMLS:C1706792


subject: CHEBI:2636

subject_name: Amifostine


subject: CHEBI:2636


subject: CHEBI:2636


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Allergic rhinoconjunctivitis


subject: CHEBI:74705

object_name: Atopic rhinitis


subject: CHEBI:74705

object_name: Allergic Rhinitis, CTCAE


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: CHEBI:3215

subject_name: Bupivacaine


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:32599


subject: CHEBI:32599


subject: CHEBI:32599


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: adult lymphoma


subject: GTOPDB:4942

object_name: lymphoma


subject: GTOPDB:4942

object_name: pediatric lymphoma


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: DRUGBANK:DB16444


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Functional mitral regurgitation


subject: UNII:71492GE1FX

subject_name: Benralizumab

object_name: hematopoietic and lymphoid cell neoplasm


subject: UNII:71492GE1FX

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:71492GE1FX

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:71492GE1FX

object_name: Adult Solid Neoplasm


subject: UNII:71492GE1FX

object_name: Solid carcinoma


subject: UNII:71492GE1FX

object_name: Childhood Solid Neoplasm


subject: UNII:71492GE1FX

object_name: Solid Neoplasm


subject: CHEBI:76016

subject_name: Vortioxetine

object_name: anxiety disorder


subject: CHEBI:60481

object_name: HIV infection


subject: CHEBI:60481

object_name: AIDS


subject: CHEBI:90926

subject_name: Tenofovir alafenamide


subject: CHEBI:90926


subject: PR:000008953

subject_name: insulin-like growth factor-binding protein 7


subject: PR:000008953


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: hypotension


subject: CHEBI:9130

object_name: Hypotension, CTCAE


subject: DRUGBANK:DB19174

object_name: colon cancer


subject: DRUGBANK:DB19174

object_name: metastatic malignant neoplasm in the lymph nodes


subject: PUBCHEM.COMPOUND:4739

subject_name: Vidarbine

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:229687


subject: CHEBI:27834

subject_name: Pentostatin


subject: PUBCHEM.COMPOUND:123134034

subject_name: Methylcobalamin

object_name: autism


subject: CHEBI:28115

subject_name: Mecobalamin


subject: CHEBI:17439

subject_name: Cyanocobalamin


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: lung cancer


subject: UMLS:C5848866

object_name: lung neoplasm


subject: UMLS:C5848866

object_name: lung carcinoma


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: malaria


subject: UNII:DNZ11VPY7Q

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C4733648

subject_name: Gallium Ga 68-NOTA-anti-HER2 Nanobody VHH1

object_name: carcinoma


subject: CHEBI:521033

subject_name: Dutasteride

object_name: prostate neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2108252

subject_name: APOLIZUMAB

object_name: adult lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2108252

object_name: lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2108252

object_name: pediatric lymphoma


subject: UMLS:C1120775

subject_name: Hu1D 10


subject: UMLS:C1120775


subject: UMLS:C1120775


subject: UNII:R318PGH5VP

subject_name: Danirixin

object_name: COPD, severe early onset


subject: UNII:R318PGH5VP

object_name: chronic obstructive pulmonary disease


subject: UMLS:C4763659

subject_name: Anti-CTLA-4/OX40 Bispecific Antibody ATOR-1015

object_name: Childhood Solid Neoplasm


subject: UMLS:C4763659

object_name: Adult Solid Neoplasm


subject: UMLS:C4763659

object_name: Solid Neoplasm


subject: UMLS:C4763659

object_name: neoplasm


subject: UNII:2WTV10SIKH

subject_name: Mitapivat

object_name: sickle cell disease


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: diffuse large B-cell lymphoma


subject: PUBCHEM.COMPOUND:435949

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:435949

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:74327


subject: CHEBI:74327


subject: CHEBI:33330

subject_name: scandium atom


subject: CHEBI:33330


subject: CHEBI:33330


subject: PR:000007182

subject_name: erythroid membrane-associated protein


subject: PR:000007182


subject: PR:000007182


subject: PR:000050188

subject_name: polymeric immunoglobulin receptor secretory component


subject: PR:000050188


subject: PR:000050188


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: UNII:I031V2H011


subject: UNII:I031V2H011


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: CHEBI:31355

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: CHEBI:50733

subject_name: nutraceutical

object_name: malnutrition


subject: MESH:C029401

subject_name: Ensure Plus


subject: CHEBI:184472

subject_name: Nitrofurantoin

object_name: Catheter-associated urinary tract infection


subject: MESH:C578177

subject_name: icon infiltrant

object_name: Incipient enamel caries


subject: UMLS:C1170584

subject_name: Restasis

object_name: Evaporative Dry Eye Disease


subject: UMLS:C1170584

object_name: Secondary Sjögren's syndrome


subject: UMLS:C1170584

object_name: Primary Sjögren's syndrome


subject: CHEBI:134723

subject_name: Asunaprevir

object_name: hepatitis C


subject: CHEBI:134723

object_name: chronic hepatitis C virus infection


subject: UMLS:C3491975


subject: UMLS:C3491975


subject: PUBCHEM.COMPOUND:71587917


subject: UMLS:C3852614


subject: CHEBI:5931

subject_name: insulin human

object_name: dry eye syndrome


subject: CHEBI:5931

object_name: Dry Eye, CTCAE


subject: CHEBI:5931

object_name: Dryness of eye


subject: CHEBI:5931

object_name: Insulin Sensitivity


subject: UMLS:C4721874

subject_name: human insulin


subject: UMLS:C4721874


subject: UMLS:C4721874


subject: UMLS:C4721874


subject: UMLS:C0306371

subject_name: Humulin R


subject: UMLS:C0306371


subject: UMLS:C0306371


subject: UMLS:C0306371


subject: UMLS:C1618891

subject_name: Injection, azacitidine, 1 mg administered

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:57505028

subject_name: Suvorexant

object_name: delirium


subject: PUBCHEM.COMPOUND:57505028

object_name: Delirium, CTCAE


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: liver carcinoma


subject: UNII:52CMI0WC3Y

object_name: biliary tract cancer


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UMLS:C3641122


subject: DRUGBANK:DB16693

subject_name: Insulin icodec

object_name: type 2 diabetes mellitus


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: Light for dates


subject: UMLS:C4301616

subject_name: fluoroestradiol (18F)

object_name: endometriosis


subject: UMLS:C5439626

subject_name: Fluoroestradiol f 18, diagnostic, 1 millicurie


subject: CHEBI:23965

subject_name: estradiol


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin

object_name: type 1 diabetes mellitus


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:6441

subject_name: Levacetylmethadol

object_name: opiate dependence


subject: CHEBI:135491

subject_name: acetylmethadol


subject: CHEBI:135332

subject_name: Dimepheptanol


subject: CHEBI:71956

subject_name: retaspimycin hydrochloride

object_name: lung cancer


subject: CHEBI:71956

object_name: lung neoplasm


subject: CHEBI:71956

object_name: lung carcinoma


subject: CHEBI:71956

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:71956

object_name: Stage IV Lung Cancer AJCC v7


subject: CHEBI:71956

object_name: Stage IV Lung Cancer AJCC v6


subject: CHEBI:71956

object_name: Stage IIIB Lung Cancer AJCC v7


subject: CHEBI:71956

object_name: Stage IIIB Lung Cancer AJCC v8


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: UMLS:C1708447

subject_name: IPI 504


subject: UMLS:C1708447


subject: UMLS:C1708447


subject: UMLS:C1708447


subject: UMLS:C1708447


subject: UMLS:C1708447


subject: UMLS:C1708447


subject: UMLS:C1708447


subject: UMLS:C3896742

object_name: triple-negative breast carcinoma


subject: UMLS:C3896742

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C3896742

object_name: neoplasm


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Pick Complex


subject: CHEBI:36791

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:36791

object_name: frontotemporal dementia


subject: CHEBI:36791

object_name: Pick disease


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:94534

subject_name: olanzapine

object_name: schizophrenia


subject: CHEBI:94534

object_name: schizophreniform disorder


subject: CHEBI:94534

object_name: schizoaffective disorder


subject: CHEBI:94534

object_name: schizophrenia 18


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601

object_name: Stomach cancer


subject: CHEBI:231601

object_name: gastric cancer


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UNII:FO8S2IW40N

subject_name: larazotide acetate

object_name: celiac disease


subject: UMLS:C1964933


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Langer mesomelic dysplasia


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204


subject: UNII:234248D0HH

subject_name: Tucatinib

object_name: HER2 positive breast carcinoma


subject: UNII:234248D0HH


subject: CHEBI:90205

subject_name: Plitidepsin

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:73313844

subject_name: Dehydrodidemnin B


subject: UMLS:C0388638

subject_name: plitidepsin


subject: UNII:M310323W0U

object_name: postherpetic neuralgia


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Coma


subject: CHEBI:4466

object_name: Unconsciousness


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:60799

subject_name: Esketamine

object_name: no feeling or sensation of skin


subject: CHEBI:60799

object_name: Sensory Loss


subject: CHEBI:60799


subject: CHEBI:60799


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: PUBCHEM.COMPOUND:44151801

subject_name: Degarelix

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:44151801

object_name: prostate cancer


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: PUBCHEM.COMPOUND:20734893

subject_name: Fluticasone furoate

object_name: asthma


subject: PUBCHEM.COMPOUND:21880659

subject_name: Vilanterol


subject: CHEBI:10093

subject_name: Yohimbine

object_name: cocaine abuse


subject: CHEBI:3392

subject_name: Carbendazim

object_name: unspecified adult solid tumor, protocol specific


subject: CHEMBL.COMPOUND:CHEMBL2108494

subject_name: INTERFERON

object_name: chronic hepatitis C virus infection


subject: CHEMBL.COMPOUND:CHEMBL2108494

object_name: cognitive disorder


subject: CHEMBL.COMPOUND:CHEMBL2108494

object_name: myalgic encephalomeyelitis/chronic fatigue syndrome


subject: CHEMBL.COMPOUND:CHEMBL2108494

object_name: endogenous depression


subject: CHEMBL.COMPOUND:CHEMBL2108494

object_name: major depressive disorder


subject: UMLS:C3652465

subject_name: Interferon


subject: UMLS:C3652465


subject: UMLS:C3652465


subject: UMLS:C3652465


subject: UMLS:C3652465


subject: UMLS:C0021747

subject_name: Interferons


subject: UMLS:C0021747


subject: UMLS:C0021747


subject: UMLS:C0021747


subject: UMLS:C0021747


subject: UMLS:C0733470

subject_name: human leukocyte interferon


subject: UMLS:C0733470


subject: UMLS:C0733470


subject: UMLS:C0733470


subject: UMLS:C0733470


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:63580


subject: CHEBI:63580


subject: CHEBI:63580


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Irritable bowel syndrome with diarrhea


subject: UMLS:C5773278

object_name: type 2 diabetes mellitus


subject: CHEBI:93109

subject_name: Semaxanib

object_name: malignant soft tissue neoplasm


subject: CHEBI:93109

object_name: sarcoma


subject: CHEBI:91083

subject_name: Romiplostim


subject: CHEBI:91083


subject: UNII:851NLB57HQ

subject_name: E-DOXEPIN

object_name: insomnia


subject: UNII:851NLB57HQ

object_name: Insomnia, CTCAE 3.0


subject: UNII:851NLB57HQ

object_name: Insomnia, CTCAE 5.0


subject: UNII:851NLB57HQ

object_name: HIV infection


subject: CHEBI:4710

subject_name: Doxepin


subject: CHEBI:4710


subject: CHEBI:4710


subject: CHEBI:4710


subject: CHEBI:9435

subject_name: Temazepam


subject: CHEBI:9435


subject: CHEBI:9435


subject: CHEBI:9435


subject: CHEBI:87681

subject_name: Ranolazine

object_name: Becker disease


subject: CHEBI:87681

object_name: Thomsen disease


subject: CHEBI:87681

object_name: Thomsen and Becker disease


subject: CHEBI:87681

object_name: paramyotonia congenita of Von Eulenburg


subject: CHEBI:87681

object_name: myotonic dystrophy type 1


subject: CHEBI:87681

object_name: myotonic dystrophy


subject: CHEBI:34945

object_name: irritable bowel syndrome with constipation


subject: UNII:7662KG2R6K

subject_name: Lubiprostone


subject: CHEBI:85993

subject_name: Palbociclib

object_name: HER2/Neu Negative


subject: CHEBI:85993

object_name: HER2 negative


subject: CHEBI:85993

object_name: Locally advanced breast cancer


subject: UMLS:C5555565

subject_name: SERD ZB-716


subject: UMLS:C5555565


subject: UMLS:C5555565

object_name: Carcinoma breast stage IV


subject: UMLS:C5555565


subject: UMLS:C1328123

subject_name: Allogeneic Tumor Cell Vaccine

object_name: prostate carcinoma


subject: UMLS:C1328123

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:54676860

object_name: Childhood Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:54676860

object_name: Adult Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:54676860

object_name: sarcoma


subject: PUBCHEM.COMPOUND:54676860

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:54676860

object_name: soft tissue sarcoma


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:22651

subject_name: ascorbate


subject: CHEBI:22651


subject: CHEBI:22651


subject: CHEBI:22651


subject: CHEBI:22651


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:167715

subject_name: L-ascorbic acid 2-sulfate


subject: CHEBI:167715


subject: CHEBI:167715


subject: CHEBI:167715


subject: CHEBI:167715


subject: UMLS:C1875441

subject_name: lidocaine / sodium chloride

object_name: Post-Operative Pain


subject: UMLS:C1875441

object_name: spinal disease


subject: UMLS:C1875441

object_name: no feeling or sensation of skin


subject: UMLS:C1875441

object_name: Sensory Loss


subject: CHEBI:67272

subject_name: Perifosine

object_name: renal carcinoma


subject: CHEBI:67272

object_name: kidney cancer


subject: CHEBI:67272

object_name: neoplasm


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: PR:000009060

subject_name: insulin-like peptide INSL5

object_name: meningeal tuberculosis


subject: PR:000013980

subject_name: Rho-related GTP-binding protein RhoF


subject: PR:000023845

subject_name: DNA-directed RNA polymerase subunit beta


subject: UniProtKB:P0A8V2

subject_name: RPOB_ECOLI DNA-directed RNA polymerase subunit beta (sprot)


subject: UMLS:C3890420

subject_name: Realgar-Indigo naturalis Formulation


subject: CHEBI:6030

subject_name: Isoniazid


subject: UNII:L24XJN68OW


subject: CHEBI:45285

subject_name: Pyrazinamide


subject: CHEBI:4877

subject_name: Ethambutol


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: PUBCHEM.COMPOUND:44287954

subject_name: HYDROCHLORTHIAZIDE

object_name: hypertension


subject: PUBCHEM.COMPOUND:44287954

object_name: Hypertension, CTCAE


subject: CHEBI:43732

subject_name: thiazole


subject: CHEBI:43732


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: acute biphenotypic leukemia


subject: PUBCHEM.COMPOUND:596

object_name: mixed phenotype acute leukemia


subject: PUBCHEM.COMPOUND:596

object_name: acute leukemia of ambiguous lineage


subject: PUBCHEM.COMPOUND:596

object_name: myeloproliferative neoplasm


subject: PUBCHEM.COMPOUND:596

object_name: Malignant myeloproliferative neoplasm


subject: PUBCHEM.COMPOUND:596

object_name: Adult Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:596

object_name: childhood myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:596

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: UNII:L15LO3W1XX

subject_name: PIVEKIMAB SUNIRINE

object_name: acute myeloid leukemia by FAB classification


subject: UNII:L15LO3W1XX

object_name: acute myeloid leukemia


subject: UNII:L15LO3W1XX


subject: UNII:L15LO3W1XX


subject: UNII:L15LO3W1XX


subject: UNII:L15LO3W1XX


subject: UNII:L15LO3W1XX


subject: UNII:L15LO3W1XX


subject: UNII:L15LO3W1XX


subject: UNII:L15LO3W1XX


subject: UNII:L15LO3W1XX


subject: UNII:L15LO3W1XX


subject: UMLS:C4684978


subject: UMLS:C4684978


subject: UMLS:C4684978


subject: UMLS:C4684978


subject: UMLS:C4684978


subject: UMLS:C4684978


subject: UMLS:C4684978


subject: UMLS:C4684978


subject: UMLS:C4684978


subject: UMLS:C4684978


subject: UMLS:C4684978


subject: UMLS:C4684978


subject: CHEBI:190523

subject_name: fructooligosaccharide

object_name: radiation proctitis


subject: CHEBI:190523

object_name: Radiation enteritis of intestine


subject: MESH:C116580


subject: MESH:C116580


subject: DRUGBANK:DB17976

object_name: CADASIL


subject: DRUGBANK:DB17976

object_name: CADASIL 1


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: transient ischemic attack


subject: CHEBI:55438

subject_name: Angiotensin 1-7

object_name: dilated cardiomyopathy 3B


subject: UMLS:C0103306


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: intrahepatic cholangiocarcinoma


subject: GTOPDB:12990

subject_name: sintilimab


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: strabismus


subject: CHEBI:9130

object_name: strabismus on exam (physical finding)


subject: UMLS:C5555834

subject_name: Ribocytokine IL-7 BNT152

object_name: Childhood Solid Neoplasm


subject: UMLS:C5555834

object_name: Adult Solid Neoplasm


subject: UMLS:C5555834

object_name: Solid Neoplasm


subject: UMLS:C5555833

subject_name: Ribocytokine IL-2 BNT153


subject: UMLS:C5555833


subject: UMLS:C5555833


subject: UNII:7K5O7P6QIU

subject_name: LONCASTUXIMAB

object_name: B-cell lymphoma refractory


subject: UNII:7K5O7P6QIU

object_name: Mantle cell lymphoma refractory


subject: UNII:7K5O7P6QIU

object_name: Follicular lymphoma refractory


subject: UNII:7K5O7P6QIU

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: UNII:7K5O7P6QIU

object_name: Refractory Neoplastic Post-Transplant Lymphoproliferative Disorder


subject: UNII:7K5O7P6QIU

object_name: Diffuse large B-cell lymphoma recurrent


subject: UNII:7K5O7P6QIU

object_name: Recurrent Neoplastic Post-Transplant Lymphoproliferative Disorder


subject: UNII:7K5O7P6QIU

object_name: B-cell lymphoma recurrent


subject: UNII:7K5O7P6QIU

object_name: Mantle cell lymphoma recurrent


subject: UNII:7K5O7P6QIU


subject: UNII:7K5O7P6QIU

object_name: Follicular lymphoma recurrent


subject: UMLS:C5447409

subject_name: Simridarlimab

object_name: myeloid neoplasm


subject: CHEBI:52717

subject_name: Bortezomib

object_name: B-cell neoplasm


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:64816

object_name: follicular lymphoma


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:8382

subject_name: Prednisone


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:7936

subject_name: Paroxetine

object_name: post-traumatic stress disorder


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Metastatic malignant neoplasm to liver


subject: UNII:2S9ZZM9Q9V

object_name: colon carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: colon cancer


subject: UNII:953A26OA1Y

subject_name: Dornase alfa


subject: UNII:953A26OA1Y

object_name: Mechanical ventilation finding


subject: PR:000006592


subject: PR:000006592


subject: UMLS:C0251564

subject_name: Pulmozyme


subject: UMLS:C0251564


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: Prader-Willi syndrome


subject: UMLS:C0384570

subject_name: Recombinant Human Growth Hormone


subject: UMLS:C2825029

subject_name: Recombinant Human Growth Hormone [EPC]


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: diabetic macular edema


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: plasma cell myeloma


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: UMLS:C5782768

subject_name: BUPivacaine 0.25% injectable solution

object_name: no feeling or sensation of skin


subject: UMLS:C5782768

object_name: Sensory Loss


subject: CHEBI:6432

subject_name: Levamisole

object_name: colorectal cancer


subject: CHEBI:6432

object_name: colorectal carcinoma


subject: CHEBI:6432

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:68595

subject_name: Telaprevir

object_name: chronic hepatitis C virus infection


subject: GTOPDB:10609

subject_name: mezagitamab

object_name: autoimmune thrombocytopenic purpura


subject: CHEMBL.COMPOUND:CHEMBL4297833

subject_name: MEZAGITAMAB


subject: UMLS:C4688355

subject_name: Mezagitamab


subject: CHEBI:72296

subject_name: Apixaban


subject: CHEBI:72296

object_name: Blood Clot


subject: CHEBI:72296

object_name: thrombosis


subject: CHEBI:72296

object_name: Thrombosis of blood vessel


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Premature Labor


subject: CHEBI:89324

object_name: Maternity blues


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C0032615

subject_name: Polyunsaturated Fatty Acids

object_name: periodontitis, chronic, adult


subject: UMLS:C0032615

object_name: chronic periodontitis


subject: CHEBI:26208

subject_name: polyunsaturated fatty acid


subject: CHEBI:26208


subject: UMLS:C3490831

subject_name: xiapex

object_name: familial Dupuytren contracture


subject: UMLS:C3490831

object_name: palmar fibromatosis


subject: UMLS:C3490831

object_name: Dupuytren's contracture (physical finding)


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: tardive dyskinesia


subject: CHEBI:16796

subject_name: Melatonin


subject: UNII:702RHR475O

subject_name: FOSBRETABULIN DISODIUM

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C0962508

subject_name: combretastatin A-4 disodium phosphate


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: colon carcinoma


subject: CHEBI:22652

object_name: colorectal cancer


subject: CHEBI:22652

object_name: colon cancer


subject: CHEBI:22652

object_name: colonic disease


subject: CHEBI:95165

object_name: Myelodysplasia


subject: CHEBI:95165

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:95165

object_name: childhood myelodysplastic syndrome


subject: CHEBI:95165

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:95165

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:95165

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:95165

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Refractory acute myeloid leukemia


subject: UNII:DPT0O3T46P

object_name: acute myeloid leukemia by FAB classification


subject: UNII:DPT0O3T46P

object_name: acute myeloid leukemia


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Compulsion


subject: CHEBI:3723

subject_name: Citalopram


subject: UNII:JE7G34JYW4

object_name: interstitial lung disease 1


subject: UNII:JE7G34JYW4

object_name: interstitial lung disease 2


subject: UMLS:C5853899


subject: UMLS:C5853899


subject: UMLS:C5444737

subject_name: Flaxseed antigen

object_name: hypertension


subject: UMLS:C5444737

object_name: Hypertension, CTCAE


subject: DRUGBANK:DB10708

subject_name: Flax seed


subject: DRUGBANK:DB10708


subject: UNII:4B33BGI082

subject_name: Cholestyramine

object_name: coronary artery disorder


subject: UNII:4B33BGI082

object_name: myocardial infarction


subject: UNII:4B33BGI082

object_name: Myocardial Infarction, CTCAE


subject: UNII:4B33BGI082

object_name: Myocardial Infarction by ECG Finding


subject: UNII:4B33BGI082

object_name: myocardial ischemia


subject: UNII:4B33BGI082

object_name: coronary atherosclerosis


subject: UNII:4B33BGI082

object_name: heart disorder


subject: UNII:4B33BGI082

object_name: hypercholesterolemia, familial, 1


subject: UNII:4B33BGI082

object_name: familial hypercholesterolemia


subject: UNII:4B33BGI082

object_name: cardiovascular disorder


subject: CHEBI:91083

subject_name: Romiplostim

object_name: thrombocytopenia


subject: CHEBI:91083

object_name: Myelodysplasia


subject: CHEBI:91083

object_name: Miller-Dieker lissencephaly syndrome


subject: CHEBI:91083

object_name: myoclonic dystonia 11


subject: UMLS:C1505595


subject: UMLS:C1505595


subject: UMLS:C1505595


subject: UMLS:C1505595


subject: UNII:DPT0O3T46P

object_name: gestational trophoblastic neoplasm


subject: UNII:DPT0O3T46P

object_name: hydatidiform mole, recurrent, 1


subject: UMLS:C5556548

subject_name: CD122-selective IL-2/Anti-CD25 Antibody-like Fusion Protein ANV419

object_name: melanoma


subject: UMLS:C5556548

object_name: skin melanoma


subject: UMLS:C5556548

object_name: metastatic melanoma


subject: UMLS:C5556548

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5556548

object_name: adult disease


subject: PUBCHEM.COMPOUND:164619

subject_name: pinitol

object_name: Insulin Sensitivity


subject: CHEBI:28548

subject_name: Methylinositol


subject: CHEBI:37208


subject: MESH:C551013

subject_name: Grazax

object_name: Allergic rhinoconjunctivitis


subject: CHEBI:42797

subject_name: Gabapentin

object_name: alcohol withdrawal


subject: CHEBI:42797

object_name: alcohol abuse


subject: CHEBI:42797

object_name: alcohol dependence


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: superior mesenteric artery syndrome


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Embolism, Tumor


subject: CHEBI:31348

object_name: Neoplasm Metastasis


subject: CHEBI:31348

object_name: Metastasis


subject: CHEBI:31348

object_name: Metastatic Lesion


subject: CHEBI:194095

subject_name: mitomycin C(1-)

object_name: Childhood Breast Carcinoma


subject: CHEBI:194095

object_name: breast carcinoma


subject: CHEBI:194095

object_name: breast cancer


subject: CHEBI:194095


subject: CHEBI:194095


subject: CHEBI:194095


subject: CHEBI:194095


subject: CHEBI:27504

subject_name: Mitomycin


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: UMLS:C2830074

object_name: Solid Neoplasm


subject: UMLS:C5834504

subject_name: MTC-DOX for Injection


subject: UMLS:C5834504

object_name: pancreatic neoplasm


subject: UMLS:C5834504

object_name: liver neoplasm


subject: UMLS:C5834504

object_name: digestive system neoplasm


subject: UMLS:C5834504

object_name: Neoplasm of the gastrointestinal tract


subject: UMLS:C5834504

object_name: colorectal neoplasm


subject: UMLS:C5834504

object_name: neoplasm of esophagus


subject: UMLS:C5834504

object_name: cholangiocarcinoma


subject: UMLS:C5834504

object_name: gastric neoplasm


subject: UMLS:C5834504

object_name: breast neoplasm


subject: UMLS:C5834504

object_name: lung neoplasm


subject: UMLS:C5834504

object_name: melanoma


subject: UMLS:C5834504

object_name: malignant soft tissue neoplasm


subject: UMLS:C5834504

object_name: sarcoma


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:17026

subject_name: Progesterone

object_name: Androgen excess


subject: CHEBI:17026

object_name: anovulation


subject: CHEBI:17026

object_name: Female infertility associated with anovulation


subject: PUBCHEM.COMPOUND:3222

object_name: Moderate albuminuria


subject: PUBCHEM.COMPOUND:3222

object_name: Sickle cell nephropathy


subject: CHEBI:4784

subject_name: Enalapril


subject: CHEBI:4784


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:28939


subject: UNII:Q4K217VGA9

subject_name: Calfactant

object_name: congenital alveolar dysplasia


subject: UNII:Q4K217VGA9

object_name: respiratory distress syndrome in premature infants


subject: UNII:Q4K217VGA9

object_name: adult acute respiratory distress syndrome


subject: UNII:Q4K217VGA9

object_name: newborn respiratory distress syndrome


subject: UNII:Q4K217VGA9

object_name: bronchopulmonary dysplasia


subject: UNII:Q4K217VGA9

object_name: Bronchopulmonary Dysplasia, AE


subject: UMLS:C1508862

subject_name: INJECTION, BEVACIZUMAB, 10 MG, Administered

object_name: colorectal cancer


subject: UMLS:C1508862

object_name: colorectal carcinoma


subject: UMLS:C1508862

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C2729368

subject_name: INJECTION, BEVACIZUMAB, 0.25 MG, Administered


subject: UMLS:C2729368


subject: UMLS:C2729368


subject: UMLS:C5203354

subject_name: Bevacizumab Liquid Injection


subject: UMLS:C5203354


subject: UMLS:C5203354


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Missed abortion


subject: CHEBI:85155

subject_name: Netupitant

object_name: Nausea post chemotherapy


subject: CHEBI:94534

subject_name: olanzapine


subject: CHEBI:6801

subject_name: Metformin

object_name: inborn mitochondrial metabolism disorder


subject: CHEBI:6801

object_name: mitochondrial disease


subject: CHEBI:6801

object_name: fibromyalgia


subject: CHEBI:6801

object_name: movement disorder


subject: CHEBI:52717

subject_name: Bortezomib

object_name: AL amyloidosis


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026

object_name: primary systemic amyloidosis


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:74331896

subject_name: Janumet

object_name: type 2 diabetes mellitus


subject: CHEBI:31654

subject_name: gliclazide


subject: CHEBI:201471

subject_name: Prochloraz Metabolite BTS 40348


subject: UMLS:C0939788

subject_name: Zometa

object_name: breast neoplasm


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: decubitus ulcer


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Mantle cell lymphoma refractory


subject: CHEBI:231614

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: CHEBI:231614

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:231614

object_name: Follicular lymphoma refractory


subject: CHEBI:231614

object_name: Marginal zone lymphoma refractory


subject: CHEBI:231614

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:231614

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:231614

object_name: Plasma cell myeloma recurrent


subject: CHEBI:231614

object_name: Diffuse large B-cell lymphoma recurrent


subject: CHEBI:231614

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:231614

object_name: Recurrent Grade 3a Follicular Lymphoma


subject: CHEBI:231614

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:231614

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:231614

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:231614

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:231614

object_name: Follicular lymphoma recurrent


subject: CHEBI:231614

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:231614

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:231614

object_name: Recurrent Non-Hodgkin Lymphoma


subject: UMLS:C2346820

object_name: Mantle cell lymphoma refractory


subject: UMLS:C2346820

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: UMLS:C2346820

object_name: Non-Hodgkin's lymphoma refractory


subject: UMLS:C2346820

object_name: Follicular lymphoma refractory


subject: UMLS:C2346820

object_name: Marginal zone lymphoma refractory


subject: UMLS:C2346820

object_name: Chronic lymphocytic leukaemia refractory


subject: UMLS:C2346820

object_name: Mantle cell lymphoma recurrent


subject: UMLS:C2346820

object_name: Plasma cell myeloma recurrent


subject: UMLS:C2346820

object_name: Diffuse large B-cell lymphoma recurrent


subject: UMLS:C2346820

object_name: Recurrent Chronic Lymphoid Leukemia


subject: UMLS:C2346820

object_name: Recurrent Grade 3a Follicular Lymphoma


subject: UMLS:C2346820

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UMLS:C2346820

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UMLS:C2346820

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: UMLS:C2346820

object_name: Marginal zone lymphoma recurrent


subject: UMLS:C2346820

object_name: Follicular lymphoma recurrent


subject: UMLS:C2346820

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: UMLS:C2346820

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: UMLS:C2346820

object_name: Recurrent Non-Hodgkin Lymphoma


subject: UNII:D959AE5USF

subject_name: clofazimine

object_name: Mycobacterium avium complex disease


subject: CHEBI:15365

subject_name: Aspirin

object_name: atrial fibrillation


subject: CHEBI:15365

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:15365

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:184023

subject_name: Argininosuccinic acid


subject: CHEBI:184023


subject: CHEBI:184023


subject: CHEBI:135207

subject_name: Clofedanol


subject: CHEBI:135207


subject: CHEBI:135207


subject: PR:000004321

subject_name: arylsulfatase A


subject: PR:000004321


subject: PR:000004321


subject: CHEBI:37941

subject_name: Clopidogrel


subject: CHEBI:37941


subject: CHEBI:37941


subject: CHEBI:87715

subject_name: Prasugrel


subject: CHEBI:87715


subject: CHEBI:87715


subject: UMLS:C2267235

subject_name: Vitamin K Antagonist [EPC]


subject: UMLS:C2267235


subject: UMLS:C2267235


subject: UMLS:C3653316

subject_name: Vitamin K antagonists


subject: UMLS:C3653316


subject: UMLS:C3653316


subject: UMLS:C4278128

subject_name: subetta

object_name: Prediabetes


subject: UMLS:C4278128

object_name: glucose intolerance


subject: UMLS:C4278128

object_name: Impaired glucose tolerance


subject: UNII:C5529G5JPQ

subject_name: ginger extract

object_name: Mental deterioration


subject: UNII:C5529G5JPQ

object_name: Cognitive impairment


subject: UNII:C5529G5JPQ

object_name: Musculoskeletal Finding


subject: CHEBI:231594

subject_name: Norgestrel

object_name: Uses contraception (finding)


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Cough


subject: CHEBI:135925

subject_name: Lisdexamfetamine

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:135925


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Sturge-Weber syndrome


subject: CHEMBL.COMPOUND:CHEMBL4297791

object_name: pancreatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297791

object_name: exocrine pancreatic carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297791

object_name: malignant pancreatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297791

object_name: cholangiocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297791

object_name: Metastatic Colon Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297791

object_name: colon carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297791

object_name: colorectal cancer


subject: CHEMBL.COMPOUND:CHEMBL4297791

object_name: colon cancer


subject: CHEMBL.COMPOUND:CHEMBL4297791

object_name: Metastatic malignant neoplasm to liver


subject: UMLS:C4287728


subject: UMLS:C4287728


subject: UMLS:C4287728


subject: UMLS:C4287728


subject: UMLS:C4287728


subject: UMLS:C4287728


subject: UMLS:C4287728


subject: UMLS:C4287728


subject: UMLS:C4287728


subject: PUBCHEM.COMPOUND:11654566

subject_name: Idelalisib

object_name: acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: thyroid tumor


subject: PUBCHEM.COMPOUND:131769963

object_name: thyroid gland carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: thyroid cancer


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: CHEMBL.COMPOUND:CHEMBL5314348

subject_name: BIVALIRUDIN

object_name: coronary artery disorder


subject: CHEMBL.COMPOUND:CHEMBL5314348

object_name: coronary atherosclerosis


subject: UMLS:C1314413

subject_name: INJECTION, BIVALIRUDIN, 1 MG ADMINISTERED


subject: UMLS:C1314413


subject: CHEBI:59173

subject_name: Bivalirudin


subject: CHEBI:59173


subject: CHEBI:521033

subject_name: Dutasteride

object_name: alcohol abuse


subject: CHEBI:521033

object_name: alcohol dependence


subject: CHEBI:521033

object_name: alcohol-related disorders


subject: UMLS:C3854029

subject_name: antiseptics ethanol


subject: UMLS:C3854029


subject: UMLS:C3854029


subject: UMLS:C3854030

subject_name: CNS depressants ethanol


subject: UMLS:C3854030


subject: UMLS:C3854030


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:16236


subject: CHEBI:16236


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: Intraoperative hypotension


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: septic shock


subject: PUBCHEM.COMPOUND:92043599

object_name: Sepsis


subject: PUBCHEM.COMPOUND:92043599

object_name: Sepsis, CTCAE


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:81579


subject: CHEBI:81579


subject: CHEBI:18248

subject_name: Iron


subject: CHEBI:18248


subject: CHEBI:18248


subject: CHEBI:18248

object_name: anemia


subject: CHEBI:18248

object_name: Anemia, CTCAE


subject: CHEBI:29034

subject_name: Ferric cation


subject: CHEBI:29034


subject: CHEBI:29034


subject: CHEBI:29034


subject: CHEBI:29034


subject: UMLS:C1166521

subject_name: Ferrum metallicum, Homeopathic preparation


subject: UMLS:C1166521


subject: UMLS:C1166521


subject: UMLS:C1166521


subject: UMLS:C1166521


subject: UMLS:C3714701

subject_name: Iron Drug Class


subject: UMLS:C3714701


subject: UMLS:C3714701


subject: UMLS:C3714701


subject: UMLS:C3714701


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: grade 3B follicular lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: precursor B-cell acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:3367

object_name: B-cell acute lymphoblastic leukemia


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:4911

subject_name: Etoposide

object_name: leukemia


subject: CHEBI:4911

object_name: childhood leukemia


subject: MESH:D000077325

subject_name: Ringer's Lactate

object_name: biliary atresia intrahepatic syndromic form


subject: UMLS:C0445115

subject_name: Normal saline


subject: PUBCHEM.COMPOUND:11756905

subject_name: Delamanid

object_name: multidrug-resistant tuberculosis


subject: PUBCHEM.COMPOUND:11756905

object_name: pulmonary tuberculosis


subject: PUBCHEM.COMPOUND:11756905

object_name: extensively drug-resistant tuberculosis


subject: UMLS:C5854537

subject_name: Anti-IGFBP2 Plasmid DNA Vaccine AST-201

object_name: non-small cell lung carcinoma


subject: UMLS:C5854537

object_name: liver carcinoma


subject: UMLS:C5854537

object_name: liver neoplasm


subject: UMLS:C5854537

object_name: neoplasm


subject: PUBCHEM.COMPOUND:91867649

object_name: anxiety


subject: PUBCHEM.COMPOUND:91867649

object_name: anxiety disorder


subject: PUBCHEM.COMPOUND:91867649

object_name: Anxiety symptoms


subject: PUBCHEM.COMPOUND:91867649

object_name: Anxiety, CTCAE 3.0


subject: PUBCHEM.COMPOUND:91867649

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:36929

subject_name: carbon-11 atom


subject: CHEBI:36929


subject: CHEBI:36929


subject: CHEBI:36929


subject: CHEBI:36929


subject: CHEBI:5103

subject_name: Flumazenil


subject: CHEBI:5103


subject: CHEBI:5103


subject: CHEBI:5103


subject: CHEBI:5103


subject: UNII:B9Z1OEH19D


subject: UNII:B9Z1OEH19D


subject: UNII:B9Z1OEH19D


subject: UNII:B9Z1OEH19D


subject: UNII:B9Z1OEH19D


subject: UMLS:C3714197


subject: UMLS:C3714197


subject: UMLS:C3714197


subject: UMLS:C3714197


subject: UMLS:C3714197


subject: CHEBI:4806

subject_name: Epigallocatechin gallate

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: UMLS:C4527194

subject_name: Protease Inhibitor Formulation LB1148

object_name: Pneumonia caused by SARS-CoV-2


subject: UMLS:C4527194


subject: UMLS:C5420753

subject_name: Gallium Ga 68-NOTA-anti-MMR-VHH2 Nanobody


subject: CHEBI:4953

subject_name: Exemestane

object_name: hormone receptor-positive breast cancer


subject: CHEBI:71219

subject_name: Pazopanib


subject: UNII:O9OC34WOAY

subject_name: Osoresnontrine

object_name: psychosis


subject: UMLS:C5961173

subject_name: HER2 Mutant-selective Inhibitor NVL-330

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C5961173

object_name: Locally Advanced Malignant Solid Neoplasm


subject: CHEBI:88337

subject_name: bisantrene

object_name: acute myeloid leukemia


subject: GTOPDB:11180

subject_name: apitegromab

object_name: Overweight and obesity


subject: CHEMBL.COMPOUND:CHEMBL4594326

subject_name: APITEGROMAB


subject: UMLS:C5421022


subject: CHEBI:6931

subject_name: Midazolam

object_name: endometriosis


subject: CHEBI:94805

subject_name: Ataluren

object_name: hemophilia B


subject: CHEBI:94805

object_name: hemophilia B leyden


subject: CHEBI:94805

object_name: hemophilia A


subject: CHEBI:136048

subject_name: Vonoprazan

object_name: Helicobacter pylori [H. pylori] infection in conditions classified elsewhere and of unspecified site


subject: PUBCHEM.COMPOUND:54675776

subject_name: tetracycline


subject: PUBCHEM.COMPOUND:54685734

subject_name: Epitetracycline


subject: UMLS:C1744619

subject_name: Tetracycline Antibiotics


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab

object_name: Stomach cancer


subject: UNII:D99YVK4L0X

object_name: gastric cancer


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C1721684


subject: CHEBI:34385

subject_name: Dalfampridine

object_name: secondary progressive multiple sclerosis


subject: CHEBI:34385

object_name: primary progressive multiple sclerosis


subject: CHEBI:91899

object_name: chronic obstructive pulmonary disease


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: mood disorder


subject: CHEBI:6950

object_name: mental disorder


subject: CHEBI:6950

object_name: psychiatric disorder


subject: CHEBI:77562

subject_name: rac-crizotinib

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:74328238

subject_name: Sotagliflozin

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:74328238

object_name: Stage 4 chronic kidney disease


subject: UMLS:C5773063

subject_name: Debio 1450

object_name: Bone Diseases, Infectious


subject: UMLS:C3852655

object_name: chronic hepatitis C virus infection


subject: CHEBI:85089

subject_name: Ledipasvir


subject: PUBCHEM.COMPOUND:25167947


subject: UNII:5NOK5X389M

subject_name: Tegobuvir


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: non-Hodgkin lymphoma


subject: CHEBI:145431

subject_name: Indisulam

object_name: skin melanoma


subject: CHEBI:6121

subject_name: Ketamine

object_name: Suicidal ideation


subject: CHEBI:6121

object_name: Suicidal Ideation, CTCAE


subject: CHEBI:6121

object_name: major depressive episode


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: Post-Operative Pain


subject: UMLS:C4086546

object_name: Perioperative complication


subject: UMLS:C4086546

object_name: heart disorder


subject: UMLS:C4086546

object_name: opioid use


subject: UNII:W89H91R7VX

subject_name: Arbaclofen Placarbil

object_name: Back Pain, CTCAE 5.0


subject: UNII:W89H91R7VX

object_name: Back pain


subject: UNII:W89H91R7VX

object_name: Back Pain, CTCAE 3.0


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: hepatoblastoma


subject: UNII:M487QF2F4V

object_name: Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7


subject: UNII:M487QF2F4V

object_name: stage I childhood liver cancer


subject: UNII:M487QF2F4V

object_name: Recurrent Childhood Liver Cancer


subject: UMLS:C1706792

subject_name: Amifostine Trihydrate


subject: UMLS:C1706792


subject: UMLS:C1706792


subject: UMLS:C1706792


subject: CHEBI:2636

subject_name: Amifostine


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: UMLS:C5565806

object_name: Hyperuricemia


subject: UMLS:C5565806

object_name: Hyperuricemia, CTCAE


subject: UMLS:C5565806

object_name: gout


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: no feeling or sensation of skin


subject: CHEBI:73604

object_name: Sensory Loss


subject: PUBCHEM.COMPOUND:3267

subject_name: Estradiol valerate

object_name: Uses oral contraception (finding)


subject: PUBCHEM.COMPOUND:13175121

subject_name: Dienogest


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:134716

subject_name: Brexpiprazole

object_name: Depressed mood


subject: CHEBI:134716

object_name: Cancer patients and suicide and depression


subject: CHEBI:134716

object_name: Depressed - symptom


subject: CHEBI:134716

object_name: Depression, CTCAE


subject: CHEBI:134716

object_name: psychosis


subject: CHEBI:134716

object_name: Nonorganic psychosis


subject: CHEBI:134716

object_name: Psychosis, CTCAE


subject: CHEBI:466659

object_name: hepatitis C


subject: CHEBI:466659

object_name: chronic hepatitis C virus infection


subject: CHEBI:68595

subject_name: Telaprevir


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b


subject: CHEBI:177430

subject_name: Setipiprant

object_name: alopecia


subject: CHEBI:177430

object_name: Alopecia, CTCAE


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: endogenous depression


subject: CHEBI:6367

object_name: major depressive disorder


subject: CHEBI:6367

object_name: schizoaffective disorder


subject: CHEBI:135686

subject_name: Alvimopan

object_name: ileus


subject: CHEBI:135686

object_name: Ileus, CTCAE


subject: CHEBI:63717

subject_name: Tenofovir disoproxil


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: large B-cell lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: Hodgkin Disease


subject: PUBCHEM.COMPOUND:3367

object_name: Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:3367

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:63599

subject_name: Fludarabine


subject: PUBCHEM.COMPOUND:137706467

subject_name: Rimiducid


subject: PUBCHEM.COMPOUND:137706467


subject: PUBCHEM.COMPOUND:137706467


subject: PUBCHEM.COMPOUND:137706467


subject: CHEBI:94770

subject_name: Pirarubicin

object_name: breast neoplasm


subject: CHEBI:90881

subject_name: Camptosar

object_name: colorectal cancer


subject: CHEBI:90881

object_name: colorectal carcinoma


subject: CHEBI:90881

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5417992

subject_name: Tobemstomig

object_name: Solid Neoplasm


subject: UMLS:C5417992

object_name: metastatic melanoma


subject: UMLS:C5417992

object_name: esophageal squamous cell carcinoma


subject: UMLS:C5417992

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:450601

subject_name: Fluciclovine (18F)

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:450601

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:10820564

subject_name: Fluciclovine


subject: PUBCHEM.COMPOUND:10820564


subject: CHEBI:134703


subject: CHEBI:134703


subject: UNII:089658A12D

subject_name: Guselkumab

object_name: psoriatic arthritis


subject: CHEBI:94531

subject_name: belinostat

object_name: Carcinoma breast stage IV


subject: CHEBI:94531

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:94531

object_name: Stage IV Ovarian Carcinoma


subject: GTOPDB:8313

subject_name: talazoparib


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: CHEBI:78420

subject_name: Icariin

object_name: bipolar disorder


subject: CHEBI:78420

object_name: Substance Use Disorders


subject: UMLS:C5854496

subject_name: Anti-CLDN6/CD3 Bispecific Antibody SAIL66

object_name: Childhood Solid Neoplasm


subject: UMLS:C5854496

object_name: Adult Solid Neoplasm


subject: UMLS:C5854496


subject: CHEBI:8024

subject_name: Perindopril

object_name: hypertension


subject: CHEBI:5893

subject_name: Indapamide


subject: UMLS:C0879250

subject_name: HER-2-neu peptide vaccine

object_name: Childhood Breast Carcinoma


subject: UMLS:C0879250

object_name: breast carcinoma


subject: UMLS:C0879250

object_name: breast cancer


subject: UMLS:C0069515

subject_name: erbB-2 Receptor


subject: UMLS:C0069515


subject: UMLS:C0069515


subject: CHEBI:95021

subject_name: pemetrexed

object_name: malignant pleural mesothelioma


subject: CHEBI:63724


subject: UMLS:C0543134

subject_name: Balanced salt solution

object_name: Epiphora


subject: UMLS:C0543134

object_name: dacryocystitis


subject: UMLS:C0543134

object_name: dacryostenosis


subject: CHEBI:8485

subject_name: Proparacaine


subject: CHEBI:8485


subject: CHEBI:8485


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: diabetes mellitus


subject: CHEBI:194186

object_name: glucose metabolism disease


subject: CHEBI:194186

object_name: endocrine system disorder


subject: CHEBI:194186

object_name: metabolic disease


subject: UMLS:C5227687

object_name: Enteric hyperoxaluria


subject: CHEMBL.COMPOUND:CHEMBL1201574

subject_name: ONABOTULINUMTOXINA

object_name: Urinary incontinence


subject: CHEMBL.COMPOUND:CHEMBL1201574

object_name: Urinary Incontinence, CTCAE 5.0


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: angioimmunoblastic T-cell lymphoma


subject: PUBCHEM.COMPOUND:2767

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: PUBCHEM.COMPOUND:2767

object_name: peripheral T-cell lymphoma, not otherwise specified


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: PUBCHEM.COMPOUND:343523

object_name: brain cancer


subject: CHEBI:49166

subject_name: fluorodopa F 18


subject: CHEBI:135915

subject_name: Thymalfasin

object_name: stage IV esophageal cancer


subject: CHEBI:135915

object_name: carcinoma of esophagus


subject: CHEBI:135915

object_name: esophageal cancer


subject: CHEBI:135915

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:135915

object_name: neoplasm of esophagus


subject: UMLS:C3180381

subject_name: AMG 108


subject: PUBCHEM.COMPOUND:4442

subject_name: Ramosetron

object_name: Nausea, CTCAE_5


subject: PUBCHEM.COMPOUND:4442

object_name: Nausea


subject: PUBCHEM.COMPOUND:4442

object_name: Nausea, CTCAE_3


subject: PUBCHEM.COMPOUND:4442

object_name: Vomiting, CTCAE


subject: PUBCHEM.COMPOUND:4442

object_name: Vomiting


subject: PUBCHEM.COMPOUND:57414794

subject_name: Dolutegravir

object_name: latent tuberculosis infection


subject: PUBCHEM.COMPOUND:57414794

object_name: Pediatric human immunodeficiency virus infection


subject: HMDB:HMDB0015332

subject_name: Rifapentine


subject: HMDB:HMDB0015332


subject: UMLS:C4548896

object_name: polymyositis


subject: CHEBI:68551

subject_name: Linaclotide

object_name: irritable bowel syndrome with constipation


subject: CHEBI:174358

subject_name: Eslicarbazepine

object_name: epilepsy


subject: CHEBI:50733

subject_name: nutraceutical

object_name: Chronic inflammation


subject: DRUGBANK:DB10571

subject_name: Strawberry

object_name: Age-related cognitive decline


subject: DRUGBANK:DB10571

object_name: obesity due to melanocortin 4 receptor deficiency


subject: DRUGBANK:DB10571

object_name: obesity


subject: DRUGBANK:DB10571

object_name: Obesity, CTCAE


subject: UMLS:C4287690

subject_name: BET Bromodomain Inhibitor ZEN-3694

object_name: triple-negative breast carcinoma


subject: UMLS:C4287690

object_name: Unresectable Malignant Solid Neoplasm


subject: UMLS:C4287690

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C4287690

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C4287690

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:145371

subject_name: Binimetinib


subject: CHEBI:145371


subject: CHEBI:145371


subject: CHEBI:145371


subject: CHEBI:5134

subject_name: Fluticasone

object_name: Stridor


subject: CHEBI:5134

object_name: Stridor, CTCAE


subject: UNII:8D7B37T28G

subject_name: SATRAPLATIN

object_name: prostate carcinoma


subject: UNII:8D7B37T28G

object_name: prostate cancer


subject: CHEBI:8888

subject_name: Ropinirole

object_name: Restless legs


subject: CHEBI:8888

object_name: Parkinson disease


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: ovarian cancer


subject: CHEBI:233362

object_name: ovarian neoplasm


subject: CHEBI:233362

object_name: ovarian carcinoma


subject: UNII:96265TNH2R

subject_name: Gedatolisib


subject: UNII:96265TNH2R


subject: UNII:96265TNH2R


subject: UNII:96265TNH2R

object_name: endometrial cancer


subject: UNII:96265TNH2R

object_name: uterine corpus cancer


subject: UNII:96265TNH2R

object_name: endometrial carcinoma


subject: UNII:C88817F47Y


subject: UNII:C88817F47Y


subject: UNII:C88817F47Y


subject: UNII:C88817F47Y


subject: UNII:C88817F47Y


subject: UNII:C88817F47Y


subject: UNII:2EWN8Z05CN

subject_name: Zotatifin


subject: UNII:2EWN8Z05CN


subject: UNII:2EWN8Z05CN


subject: UNII:2EWN8Z05CN


subject: UNII:2EWN8Z05CN


subject: UNII:2EWN8Z05CN


subject: UMLS:C0658617

object_name: Childhood Breast Carcinoma


subject: UMLS:C0658617

object_name: breast carcinoma


subject: UMLS:C0658617

object_name: breast cancer


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: GTOPDB:13826

subject_name: pegcetacoplan

object_name: cold agglutinin disease


subject: GTOPDB:13826

object_name: autoimmune hemolytic anemia, cold type


subject: UNII:TO3JYR3BOU

subject_name: Pegcetacoplan


subject: UNII:TO3JYR3BOU


subject: CHEBI:72297

subject_name: Lomitapide

object_name: hypercholesterolemia, familial, 1


subject: CHEBI:72297

object_name: familial hypercholesterolemia


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: allergic asthma


subject: CHEBI:9667

subject_name: Triamcinolone


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: nonpapillary renal cell carcinoma


subject: UNII:52CMI0WC3Y

object_name: clear cell renal carcinoma


subject: UNII:52CMI0WC3Y

object_name: renal cell adenocarcinoma


subject: UNII:52CMI0WC3Y

object_name: renal cell carcinoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UMLS:C4329323


subject: UMLS:C4329323


subject: UMLS:C4329323


subject: UMLS:C4329323


subject: UNII:H9E1T0BI90

subject_name: DESVENLAFAXINE SUCCINATE

object_name: endogenous depression


subject: UNII:H9E1T0BI90

object_name: major depressive disorder


subject: UMLS:C5966113

subject_name: CDK8/19 Inhibitor RVU120

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5237424

subject_name: CDK8/19 Inhibitor SEL 120


subject: UMLS:C5237424

object_name: acute myeloid leukemia


subject: UMLS:C1614968

subject_name: Sativex

object_name: cancer


subject: UMLS:C1614968

object_name: neoplasm


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Myelodysplasia


subject: CHEBI:38290

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:38290

object_name: childhood myelodysplastic syndrome


subject: CHEBI:38290

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: PUBCHEM.COMPOUND:87184527

subject_name: Sodium potassium citrate

object_name: Kidney Calculi


subject: UMLS:C0770575

subject_name: potassium citrate / sodium citrate


subject: UMLS:C4682749

object_name: non-small cell lung carcinoma


subject: UMLS:C4310525

object_name: Impaired dark adaptation


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Relapse multiple myeloma


subject: CHEBI:90942

subject_name: Ixazomib


subject: CHEBI:90942

object_name: Plasma cell myeloma recurrent


subject: CHEBI:72690

subject_name: Pomalidomide


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: esophageal squamous cell carcinoma


subject: GTOPDB:4934

subject_name: G-CSF

object_name: Immunoglobulin deposition disease


subject: GTOPDB:4934

object_name: AL amyloidosis


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: UMLS:C5238055

subject_name: Tengonermin

object_name: colon carcinoma


subject: UMLS:C5238055

object_name: colorectal cancer


subject: UMLS:C5238055

object_name: colon cancer


subject: UMLS:C1143119

subject_name: Zafiride


subject: UMLS:C1143119


subject: UMLS:C1143119


subject: UNII:69VKY8P7EA

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UNII:69VKY8P7EA

object_name: stage IV pancreatic cancer


subject: UNII:69VKY8P7EA

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UNII:69VKY8P7EA

object_name: Pancreatic carcinoma recurrent


subject: UNII:69VKY8P7EA

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UNII:69VKY8P7EA

object_name: Pancreatic carcinoma stage III


subject: UNII:69VKY8P7EA

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UNII:69VKY8P7EA

object_name: unspecified adult solid tumor, protocol specific


subject: UNII:69VKY8P7EA

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C2700458

subject_name: Dovitinib Lactate


subject: UMLS:C2700458


subject: UMLS:C2700458


subject: UMLS:C2700458


subject: UMLS:C2700458


subject: UMLS:C2700458


subject: UMLS:C2700458


subject: UMLS:C2700458


subject: UMLS:C2700458


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:32150

object_name: calciphylaxis


subject: CHEBI:32150

object_name: Chronic uremia


subject: CHEBI:132112


subject: CHEBI:132112


subject: UMLS:C1172837

subject_name: Product R

object_name: Anorexia


subject: UMLS:C1172837

object_name: Anorexia, CTCAE


subject: UMLS:C1172837

object_name: Anorexia symptom


subject: UMLS:C1172837

object_name: Malignant cachexia


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: retinal disease


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab


subject: CHEBI:119915

subject_name: Fentanyl

object_name: cancer


subject: CHEBI:119915

object_name: neoplasm


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Childhood Solid Neoplasm


subject: UNII:2S9ZZM9Q9V

object_name: Adult Solid Neoplasm


subject: UNII:2S9ZZM9Q9V

object_name: Solid Neoplasm


subject: CHEBI:114785

subject_name: Erlotinib


subject: CHEBI:114785


subject: CHEBI:114785


subject: GTOPDB:8966

subject_name: onartuzumab


subject: GTOPDB:8966


subject: GTOPDB:8966


subject: CHEMBL.COMPOUND:CHEMBL1743051

subject_name: ONARTUZUMAB


subject: CHEMBL.COMPOUND:CHEMBL1743051


subject: CHEMBL.COMPOUND:CHEMBL1743051


subject: UMLS:C2826110


subject: UMLS:C2826110


subject: UMLS:C2826110


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: leukemia


subject: CHEBI:201431

object_name: childhood leukemia


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4911

subject_name: Etoposide

object_name: Myelodysplasia


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: GTOPDB:12989

subject_name: toripalimab

object_name: liver carcinoma


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: CHEBI:5855

subject_name: Ibuprofen

object_name: prostate carcinoma


subject: CHEBI:5855

object_name: prostate cancer


subject: CHEBI:5855

object_name: prostatitis


subject: CHEBI:5855

object_name: pleomorphic adenoma


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: heart failure


subject: CHEBI:25681

object_name: Heart Failure, CTCAE


subject: CHEBI:38867

subject_name: anaesthetic

object_name: Autonomic nervous system imbalance


subject: UMLS:C0002932

subject_name: Anesthetics


subject: UMLS:C4722058

subject_name: Anesthetics [TC]


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Lung Injury


subject: CHEBI:6888


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: GTOPDB:10492

subject_name: envafolimab

object_name: Advanced Hepatocellular Carcinoma


subject: UNII:ES1M06M6QH


subject: UMLS:C4329339


subject: CHEBI:149509

object_name: Cognitive impairment


subject: CHEBI:149509

object_name: hypertension


subject: CHEBI:149509

object_name: Hypertension, CTCAE


subject: CHEBI:3347

subject_name: Candesartan


subject: CHEBI:3347


subject: CHEBI:3347


subject: CHEBI:6503

subject_name: LISINOPRIL


subject: CHEBI:43755

subject_name: Lisinopril


subject: CHEBI:6904

subject_name: Metoprolol


subject: CHEBI:6904


subject: CHEBI:6904


subject: CHEBI:7565

subject_name: Nifedipine


subject: CHEBI:7565


subject: CHEBI:7565


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:43805

object_name: ovarian neoplasm


subject: PUBCHEM.COMPOUND:43805

object_name: ovarian carcinoma


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C0592999

subject_name: avaxim

object_name: malaria


subject: CHEMBL.COMPOUND:CHEMBL4297828

object_name: Small cell lung cancer extensive stage


subject: UMLS:C4725109


subject: PUBCHEM.COMPOUND:71300864

object_name: Heart failure with reduced ejection fraction


subject: UMLS:C2933615

subject_name: LCZ 696


subject: UMLS:C1508862

subject_name: INJECTION, BEVACIZUMAB, 10 MG, Administered

object_name: proliferative diabetic retinopathy


subject: UMLS:C1508862

object_name: diabetic retinopathy


subject: UMLS:C1508862

object_name: Vascular endothelial growth factor overexpression


subject: UMLS:C2729368

subject_name: INJECTION, BEVACIZUMAB, 0.25 MG, Administered


subject: UMLS:C2729368


subject: UMLS:C2729368


subject: UMLS:C5203354

subject_name: Bevacizumab Liquid Injection


subject: UMLS:C5203354


subject: UMLS:C5203354


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: CHEBI:32139

object_name: contrast-induced nephropathy


subject: CHEBI:32139

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:32139

object_name: aortic valve disorder


subject: CHEBI:32139

object_name: aortic valve disease 1


subject: CHEBI:32139

object_name: Aortic Valve Disease, CTCAE


subject: UNII:UMD07X179E

subject_name: CERTOLIZUMAB

object_name: ankylosing spondylitis


subject: UNII:UMD07X179E

object_name: rheumatoid arthritis


subject: UNII:UMD07X179E

object_name: psoriatic arthritis


subject: UNII:UMD07X179E

object_name: Crohn disease


subject: UMLS:C1172157


subject: UMLS:C1172157


subject: UMLS:C1172157


subject: UMLS:C1172157


subject: PUBCHEM.COMPOUND:126480232

subject_name: Cobomarsen

object_name: mycosis fungoides


subject: UNII:3JKW7CI9IU

subject_name: COBOMARSEN


subject: PUBCHEM.COMPOUND:86278354

subject_name: Emapticap pegol

object_name: anemia due to chronic disorder


subject: UNII:CTL75X0V60


subject: CHEBI:144094

subject_name: bicalutamide

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:144094

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:144094

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:144094

object_name: Stage IV Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:4400717

subject_name: GnRH (free acid


subject: PUBCHEM.COMPOUND:4400717


subject: PUBCHEM.COMPOUND:4400717


subject: PUBCHEM.COMPOUND:4400717


subject: CHEBI:5520

subject_name: gonadorelin


subject: CHEBI:5520


subject: CHEBI:5520


subject: CHEBI:5520


subject: PR:000008127


subject: PR:000008127


subject: PR:000008127


subject: PR:000008127


subject: UMLS:C2987634

subject_name: Agonist


subject: UMLS:C2987634


subject: UMLS:C2987634


subject: UMLS:C2987634


subject: GTOPDB:13791

subject_name: sacituzumab tirumotecan

object_name: superficial urinary bladder carcinoma


subject: UNII:3DV5TD1VL3

subject_name: SACITUZUMAB TIRUMOTECAN


subject: UMLS:C5237963

subject_name: ADC SKB264


subject: PUBCHEM.COMPOUND:1972

subject_name: Fungizone

object_name: Mycoses


subject: CHEBI:2682

subject_name: Amphotericin B


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: malignant soft tissue neoplasm


subject: CHEBI:231005

object_name: sarcoma


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: CHEBI:175901

subject_name: Gemcitabine


subject: UMLS:C0876134

subject_name: Prevnar

object_name: Recurrent acute otitis media


subject: CHEBI:134709

subject_name: Pitolisant

object_name: recurrent hypersomnia


subject: CHEBI:134709

object_name: idiopathic hypersomnia


subject: CHEBI:134709

object_name: Somnolence


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: Childhood Neuroblastoma


subject: CHEBI:6067

object_name: neuroblastoma


subject: UNII:9K8GNJ2874

subject_name: Naxitamab


subject: UNII:9K8GNJ2874


subject: UMLS:C4054758

subject_name: naxitamab


subject: UMLS:C4054758


subject: CHEBI:94534

subject_name: olanzapine

object_name: bipolar disorder


subject: CHEBI:44915

subject_name: Propofol

object_name: atrial fibrillation


subject: CHEBI:44915

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:44915

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:229906

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:22175537

subject_name: Lapaquistat acetate


subject: UMLS:C2825674

subject_name: Lapaquistat Acetate


subject: UMLS:C0242402

subject_name: Opioids

object_name: endometrial cancer


subject: UMLS:C0242402

object_name: uterine corpus cancer


subject: UMLS:C0242402

object_name: endometrial carcinoma


subject: UMLS:C0242402

object_name: Childhood Breast Carcinoma


subject: UMLS:C0242402

object_name: breast carcinoma


subject: UMLS:C0242402

object_name: breast cancer


subject: UMLS:C0242402

object_name: ovarian cancer


subject: UMLS:C0242402

object_name: ovarian neoplasm


subject: UMLS:C0242402

object_name: ovarian carcinoma


subject: UMLS:C0242402

object_name: cervical cancer


subject: UMLS:C0242402

object_name: cervical carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2134724

subject_name: IPRATROPIUM BROMIDE

object_name: asthma


subject: CHEBI:5957

subject_name: ipratropium bromide hydrate


subject: PUBCHEM.COMPOUND:3021749


subject: UNII:J697UZ2A9J


subject: PUBCHEM.COMPOUND:657309

subject_name: Ipratropium


subject: CHEBI:66910

subject_name: Axitinib

object_name: acoustic neuroma


subject: CHEBI:66910

object_name: neurofibromatosis


subject: CHEBI:66910

object_name: NF2-related schwannomatosis


subject: CHEBI:66910

object_name: vestibular schwannomatosis


subject: UNII:8202AY8I7H

subject_name: Eptinezumab

object_name: migraine


subject: UNII:8202AY8I7H

object_name: migraine with or without aura, susceptibility to, 1


subject: UMLS:C4085974

object_name: prostate carcinoma


subject: UMLS:C4085974

object_name: prostate cancer


subject: UMLS:C4085974

object_name: prostate adenocarcinoma


subject: PUBCHEM.COMPOUND:44151801

subject_name: Degarelix


subject: UMLS:C0971731


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: breast neoplasm


subject: CHEBI:231087

subject_name: Trilaciclib


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: rheumatoid arthritis


subject: CHEBI:474053

subject_name: Cefazolin

object_name: preterm premature rupture of the membranes


subject: CHEBI:3732

subject_name: Clarithromycin


subject: CHEBI:9150

subject_name: Simvastatin

object_name: atrial fibrillation


subject: CHEBI:9150

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:9150

object_name: Atrial Fibrillation, CTCAE


subject: UNII:513P80B4YJ

subject_name: Avapritinib

object_name: Plexosarcoma


subject: CHEBI:90943

subject_name: Osimertinib

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:90943

object_name: Non-small cell lung cancer stage III


subject: CHEBI:90943

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:90943

object_name: Non-small cell lung cancer stage IIIA


subject: CHEBI:90943

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:90943

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: CHEBI:91450

subject_name: Sapanisertib


subject: CHEBI:91450


subject: CHEBI:91450


subject: CHEBI:91450


subject: CHEBI:91450


subject: CHEBI:91450


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Conn's syndrome


subject: CHEBI:93847

subject_name: Aceclidine

object_name: presbyopia


subject: UMLS:C0148199

subject_name: Vascular Endothelial Growth Factor Receptor

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:4672

subject_name: Docetaxel


subject: UNII:939U7C91AI

subject_name: Solriamfetol

object_name: Somnolence


subject: UNII:939U7C91AI

object_name: obstructive sleep apnea syndrome


subject: UNII:939U7C91AI

object_name: hypersomnia


subject: UNII:939U7C91AI

object_name: narcolepsy


subject: UMLS:C4726586

subject_name: ADC DS-1062a

object_name: Childhood Breast Carcinoma


subject: UMLS:C4726586

object_name: breast carcinoma


subject: UMLS:C4726586

object_name: breast cancer


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:63791

object_name: Hodgkin Disease


subject: PUBCHEM.COMPOUND:3425

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:3425


subject: PUBCHEM.COMPOUND:3425

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:3425


subject: CHEBI:61080

subject_name: Romidepsin


subject: CHEBI:61080


subject: CHEBI:61080


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Pneumonia caused by SARS-CoV-2


subject: CHEBI:9168

object_name: pulmonary fibrosis


subject: CHEBI:9168

object_name: Pulmonary Fibrosis, CTCAE


subject: CHEBI:9168

object_name: long COVID-19


subject: CHEBI:64816

object_name: adult lymphoma


subject: CHEBI:64816

object_name: lymphoma


subject: CHEBI:64816

object_name: pediatric lymphoma


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: PUBCHEM.COMPOUND:21634109

subject_name: Lacosamide

object_name: neuropathy, small fiber


subject: PUBCHEM.COMPOUND:21634109

object_name: primary erythermalgia


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: Stage IV Colon Cancer AJCC v8


subject: UNII:15C2VL427D

object_name: Stage IV Colon Cancer AJCC v6


subject: UNII:15C2VL427D

object_name: Stage IV Colon Cancer AJCC v7


subject: UNII:15C2VL427D

object_name: Malignant neoplasm of colon stage IV


subject: UNII:15C2VL427D

object_name: Stage IV Rectal Cancer AJCC v8


subject: UNII:15C2VL427D

object_name: Stage IV Rectal Cancer AJCC v7


subject: UNII:15C2VL427D

object_name: Rectal cancer stage IV


subject: UNII:15C2VL427D

object_name: Stage IV Rectal Cancer AJCC v6


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174

object_name: colon mucinous adenocarcinoma


subject: CHEBI:191174

object_name: colon signet ring cell adenocarcinoma


subject: CHEBI:191174

object_name: rectal signet ring cell adenocarcinoma


subject: CHEBI:191174

object_name: rectum mucinous adenocarcinoma


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:23965

subject_name: estradiol

object_name: Menopause present (finding)


subject: CHEBI:23965

object_name: Menopause


subject: CHEBI:17026

subject_name: Progesterone


subject: CHEBI:17026


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: UMLS:C2757070


subject: GTOPDB:13497

subject_name: axatilimab

object_name: Childhood Breast Carcinoma


subject: GTOPDB:13497

object_name: breast carcinoma


subject: GTOPDB:13497

object_name: breast cancer


subject: GTOPDB:13497

object_name: triple-negative breast carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594608

subject_name: AXATILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594608


subject: CHEMBL.COMPOUND:CHEMBL4594608


subject: CHEMBL.COMPOUND:CHEMBL4594608


subject: UMLS:C4733597


subject: UMLS:C4733597


subject: UMLS:C4733597


subject: UMLS:C4733597


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: Lumbar spine degeneration


subject: CHEBI:36080

subject_name: protein

object_name: spinal cord injury


subject: UMLS:C0033684

subject_name: Proteins


subject: PR:000000001


subject: CHEBI:95021

subject_name: pemetrexed

object_name: pleural mesothelioma


subject: CHEBI:63724


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767

object_name: malignant pleural mesothelioma


subject: CHEBI:32150


subject: CHEBI:32150


subject: CHEBI:132112


subject: CHEBI:132112


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: Relapse multiple myeloma


subject: UMLS:C1709429


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:6121

subject_name: Ketamine

object_name: endometriosis


subject: CHEBI:6121

object_name: Chronic pelvic pain of female


subject: UNII:90ZX3Q3FR7

subject_name: Risankizumab

object_name: inflammatory bowel disease 1


subject: UNII:90ZX3Q3FR7

object_name: Crohn disease


subject: UMLS:C4078397


subject: UMLS:C4078397


subject: CHEBI:133023

subject_name: Lifitegrast

object_name: dry eye syndrome


subject: CHEBI:133023

object_name: Dry Eye, CTCAE


subject: CHEBI:133023

object_name: Dryness of eye


subject: CHEBI:133023

object_name: eyes dry chronic


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Hypercholesterolemia


subject: UMLS:C5854369

subject_name: Site Specific Immunomodulator QBECO

object_name: colorectal cancer


subject: UMLS:C5854369

object_name: colorectal carcinoma


subject: UMLS:C5854369

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5854369

object_name: Metastatic malignant neoplasm to liver


subject: PUBCHEM.COMPOUND:2767

object_name: female reproductive organ cancer


subject: DRUGBANK:DB18189

subject_name: AGuIX


subject: CHEBI:9434

subject_name: Telmisartan

object_name: Alzheimer disease


subject: UMLS:C4733618

subject_name: Gallium Ga 68-NeoB

object_name: Prostate cancer recurrent


subject: UMLS:C4733618

object_name: prostate adenocarcinoma


subject: UMLS:C4733618

object_name: PSA Progression


subject: CHEMBL.COMPOUND:CHEMBL2109256

object_name: anaplastic large cell lymphoma


subject: UMLS:C1328236

subject_name: BRENTUXIMAB


subject: CHEBI:6129

subject_name: Ketorolac

object_name: acute pain due to trauma


subject: UMLS:C5392723


subject: CHEBI:7035

subject_name: Muscimol

object_name: Parkinson disease


subject: UMLS:C1704263

subject_name: green tea extract


subject: CHEBI:4806

subject_name: Epigallocatechin gallate


subject: CHEBI:70255


subject: UMLS:C0018064

subject_name: Equine Gonadotropins


subject: UNII:3934EF02T7

subject_name: Piflufolastat F 18

object_name: prostate carcinoma


subject: UNII:3934EF02T7

object_name: prostate cancer


subject: UNII:3934EF02T7


subject: UNII:3934EF02T7

object_name: metastatic prostate carcinoma


subject: UNII:3934EF02T7


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: IgM monoclonal gammopathy of uncertain significance


subject: PUBCHEM.COMPOUND:71226663

object_name: Waldenstrom macroglobulinemia


subject: PUBCHEM.COMPOUND:71226663

object_name: neuropathy


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: leukemia


subject: CHEBI:25681

object_name: childhood leukemia


subject: CHEBI:25681

object_name: adult lymphoma


subject: CHEBI:25681

object_name: lymphoma


subject: CHEBI:25681

object_name: pediatric lymphoma


subject: UMLS:C3536908

subject_name: Omega-3 Fatty Acid [EPC]


subject: UMLS:C3536908


subject: UMLS:C3536908


subject: UMLS:C3536908


subject: UMLS:C3536908


subject: UMLS:C1260600

subject_name: phosphate enema

object_name: irritable bowel syndrome


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: ovarian hyperstimulation syndrome


subject: DRUGBANK:DB17952

object_name: multiple sclerosis


subject: UMLS:C3253986

object_name: HIV infection


subject: UNII:306ERL82IR

subject_name: Fexinidazole

object_name: Decreased liver function


subject: UNII:U2I8T43Y7R

subject_name: axicabtagene ciloleucel

object_name: large B-cell lymphoma


subject: UNII:U2I8T43Y7R

object_name: follicular lymphoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: adult acute myeloid leukemia


subject: CHEBI:4026

object_name: childhood acute myeloid leukemia


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: UNII:4ON7FF680U

subject_name: TUCOTUZUMAB CELMOLEUKIN

object_name: ovarian cancer


subject: UNII:4ON7FF680U

object_name: ovarian neoplasm


subject: UNII:4ON7FF680U

object_name: ovarian carcinoma


subject: UMLS:C1530077


subject: UMLS:C1530077


subject: UMLS:C1530077


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: retinal vein occlusion


subject: CHEBI:31623

subject_name: Fluocinolone acetonide

object_name: type 2 diabetes mellitus


subject: CHEBI:31623

object_name: Diabetes


subject: CHEBI:31623

object_name: diabetes mellitus


subject: CHEBI:31623

object_name: diabetic macular edema


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: methamphetamine dependence


subject: UMLS:C3490787

subject_name: BF-200 ALA

object_name: actinic keratosis


subject: CHEBI:77260

subject_name: Omeprazole

object_name: Heartburn


subject: CHEBI:7772

subject_name: omeprazole


subject: CHEBI:32139


subject: UNII:WJA5UO9E10

subject_name: Orelabrutinib


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: acne


subject: CHEBI:174615

object_name: osteopetrosis


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:4026


subject: CHEBI:4027


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:188637

subject_name: Evacetrapib

object_name: liver failure


subject: UNII:51XWV9K850


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: thrombotic thrombocytopenic purpura


subject: UNII:4F4X42SYQ6

object_name: Thrombotic Thrombocytopenic Purpura, CTCAE


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: CHEBI:5134

subject_name: Fluticasone

object_name: Atopic rhinitis


subject: CHEBI:5134

object_name: Allergic Rhinitis, CTCAE


subject: CHEBI:83353

subject_name: Agalsidase beta

object_name: Fabry disease


subject: UNII:DLE8519RWM

subject_name: ENFORTUMAB

object_name: urothelial carcinoma


subject: UNII:DLE8519RWM

object_name: transitional cell carcinoma


subject: UMLS:C3896914


subject: UMLS:C3896914


subject: CHEBI:93274

subject_name: Fluvoxamine

object_name: Coronavinae infectious disease


subject: UMLS:C3491009

object_name: glioblastoma


subject: UMLS:C3491009

object_name: Childhood Glioblastoma